BmKCTa, the most common CTX-like peptide investigated, also demonstrated the inhibition of glioma cell proliferation, migration, and invasion in a fashion similar to CTX with MMP-2 as the potential target [211,235,316,351,355,359,360,361]. This evidence concerns the gene MMP2 and central nervous system cancer.